Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 331 of 6351
-
Could a drug for rare blood disorder help pregnant women with severe preeclampsia?
Disease control Recruiting nowThe researchers are testing a medication named ravulizumab for the treatment of severe preeclampsia and Hemolysis, Elevated Liver enzymes, Low Platelets (HELLP) syndrome.
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pill combo aims to control CLL without lifelong treatment
Disease control Not yet recruitingThis is an open-label, single-arm, phase II study which will assess the safety and efficacy of BGB16673 in combination with sonrotoclax as a time-limited approach for participants with treatment-naive CLL/SLL.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Stem cell injection during bypass surgery aims to repair damaged hearts
Disease control Not yet recruitingThis clinical study will evaluate the safety and tolerability of HiCM-188, an investigational allogeneic induced pluripotent stem cell (iPSC)-derived cardiomyocyte therapy, in adults with advanced heart failure who are undergoing coronary artery bypass grafting (CABG) surgery. P…
Phase 1/2 • Sponsor: HELP Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Your DNA may decide which obesity drug works best
Disease control Not yet recruitingA pragmatic, randomized, parallel-arm, controlled study of weight loss outcomes using AOMs guided by MyPhenome test.
Sponsor: Phenomix Sciences • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Brain-training with neurofeedback may help tame crack cocaine cravings — a trial puts it to the test
Disease control Not yet recruitingThe goal of this randomized clinical trial is to verify if a Scott-Kaiser neurofeedback protocol can improve inhibitory control, reduce craving, and enhance treatment adherence in individuals with crack cocaine use disorder. The main research question is: does a 30-session, mult…
Sponsor: Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could a new drug make gallbladder surgery recovery smoother?
Symptom relief Not yet recruitingThis study is a multicenter, randomized, 1:1 parallel-group controlled clinical trial designed to evaluate the efficacy and safety of Anrikefon for postoperative analgesia in patients undergoing elective laparoscopic cholecystectomy (LC) under general anesthesia. Enrolled patient…
Phase 2 • Sponsor: Affiliated Hospital of Guangdong Medical University • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Could a daily eye gel replace injections for wet AMD?
Disease control Not yet recruitingThis is a first-in-human clinical trial evaluating the safety and tolerability of BETA-TT8 Ophthalmic Gel in people with wet age-related macular degeneration (AMD). Approximately 24 participants with stable wet AMD who have previously received at least three anti- Vascular Endoth…
Phase 1/2 • Sponsor: Filamon LTD • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a new pill silence stubborn hives?
Disease control Not yet recruitingTHB335-201 is a Phase 2, randomized, double-blind, placebo-controlled, parallel-group, multicenter study in adults with CSU who remain symptomatic despite standard-of-care treatment. The study includes a Screening Period of up to 4 weeks, a 12-week Treatment Period, and a 4-week …
Phase 2 • Sponsor: Calixis Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Massage therapy may offer a Drug-Free path to better sleep
Symptom relief Not yet recruitingThis randomized controlled trial will investigate the effects of connective tissue massage on insomnia severity, objective and subjective sleep outcomes, and stress- and autonomic-related biomarkers in adults with chronic insomnia. Chronic insomnia is a common sleep disorder char…
Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Can a new injection tame the toxic ammonia of urea cycle disorders?
Disease control Not yet recruitingPhase 1/2 Study of KRRO-121 is a randomized, placebo-controlled study in Healthy Volunteers (Phase 1 SAD and MAD) and Study Participants with Urea Cycle Disorders (Phase 2). The primary objective of the study is to evaluate the safety of KRRO-121.
Phase 1/2 • Sponsor: Korro Bio, Inc. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a Dual-Action antibody outsmart advanced solid tumors?
Disease control Not yet recruitingThis study is an open-label, multicenter, dose-escalation and expansion, non-randomized Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of SI-B036 bispecific antibody injection in patients with locally advance…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
A rapid test to solve the TB lymph node puzzle
Diagnosis Not yet recruitingThis prospective, multi-center study aims to evaluate the Molecular Bacterial Load Assay (MBLA) on lymph node aspirates as a tool to distinguish between late immune reconstitution inflammatory syndrome (IRIS) and treatment failure in patients with extrapulmonary tuberculosis (TB)…
Sponsor: Research Center Borstel • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
Can a natural compound block Alzheimer's brain damage?
Disease control Not yet recruitingInvestigators propose a phase 1b/2a, randomized, double-blind, placebo-controlled, parallel group dose finding and biomarker study to evaluate the safety, tolerability, and biomarker activity of 2-HOBA in 48 MCI/AD participants. Participants will be randomized 1:1:1:1 to receive …
Phase 1/2 • Sponsor: MTI Biotech Inc • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
A sip of science: probiotic milk drink targets gut and metabolism
Disease control By invitation onlyThe aim of the study will be to evaluate the effectiveness of dietary therapy using a functional dairy product, using fermented milk with selected probiotic cultures, in individuals with irritable bowel syndrome and metabolic syndrome. The technology for preparing fermented milk…
Sponsor: Warsaw University of Life Sciences • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a pill tame obesity? new oral drug heads to early human tests
Disease control Not yet recruitingThis is a Phase 1 study of IBI3042, an investigational oral medicine being developed as a potential treatment for overweight and obesity. The study has two parts. Part A will evaluate single doses of IBI3042 in healthy adults. Part B will evaluate repeated doses for 13 weeks in a…
Phase 1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Exercise after scoliosis surgery: a path to better balance?
Symptom relief Not yet recruitingAdolescent idiopathic scoliosis (AIS) is a three-dimensional spinal deformity occurring in growing individuals. In cases with progressive curvature, posterior spinal fusion and instrumentation (PSF) is considered the gold-standard surgical treatment for correcting the deformity a…
Sponsor: Marmara University • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Heart risk in rheumatoid arthritis: could a blood vessel drug help?
Disease control Not yet recruitingThe goal of this clinical trial is to learn about the effects of adding nicorandil to conventional Disease-Modifying Antirheumatic Drugs(DMARDs) in treatment of patients with rheumatoid arthritis. The main questions it aims to answer are: Does adding nicorandil to conventional D…
Phase 3 • Sponsor: Tanta University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could pausing psychiatric pills boost PTSD therapy?
Disease control Not yet recruitingPost-traumatic stress disorder (PTSD) is commonly treated with trauma-focused psychotherapy, including prolonged exposure therapy and eye movement desensitization and reprocessing (EMDR). Patients frequently also use psychotropic medications for insomnia, anxiety, or other PTSD-r…
Sponsor: Academic Centre for Dentistry in Amsterdam • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a simple blood test spot pancreatic cancer early enough to save lives?
Diagnosis Not yet recruitingThe goal of this observational registry is to examine the changes made to pancreatic cancer surveillance management following the real-world clinical use of PancreaSure testing among individuals at increased risk for pancreatic ductal adenocarcinoma. The main question it aims to …
Sponsor: Immunovia, Inc. • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
Can an oral drug R01 fight advanced lung, stomach, and esophageal cancers?
Disease control Not yet recruitingThis is a Phase I(Ib), open-label, single-arm clinical study designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of R01 administered orally as monotherapy twice daily (BID) in patients with advanced solid tumors, including squamous cell …
Phase 1 • Sponsor: Beijing Anjianxi Bio-Medical Technology Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC